February 4, 2022 / Clinical Trials,Webinars

WATCH: FibroGen DMD Pamrevlumab Phase 3 Clinical Studies Highlight (Webinar Recording)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

FibroGen joined PPMD for a webinar on February 2, 2022. During the webinar, FibroGen discussed the clinical rationale for the use of Pamrevlumab by highlighting its Phase 2 study in non-ambulatory participants with Duchenne and provided an update on its Phase 3 094 study in ambulatory participants with Duchenne.

If you missed the live event, the recording can be found below.

 

Watch the Recording

Join Our Mailing List

This field is for validation purposes and should be left unchanged.
BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo